Analyst Activity – Cann Reiterates Buy on Kura Oncology (NASDAQ:KURA)

ME Staff
-
0

Analyst Ratings For Kura Oncology (NASDAQ:KURA)

Today, Cann reiterated its Buy rating on Kura Oncology (NASDAQ:KURA) with a price target of $30.00.

Some recent analyst ratings include

  • 2/16/2018-Cann Reiterated Rating of Buy.
  • 12/26/2017-Wedbush initiated coverage with a Buy rating.
  • 9/7/2017-Cowen initiated coverage with a Outperform rating.
  • 8/10/2017-Leerink Swann Reiterated Rating of Outperform.


    Recent Trading Activity for Kura Oncology (NASDAQ:KURA)
    Shares of Kura Oncology closed the previous trading session at 22.20 up +1.15 5.46% with 21.399999618530273 shares trading hands.